白介素1ζ(IL1z)活性蛋白
Active Interleukin 1 Zeta (IL1z)
IL1F7; IL37; FIL1; FIL1(ZETA); FIL1Z; IL-1F7; IL-1H4; IL-1RP1; IL1H4; IL1RP1; Interleukin 37; Interleukin-1-Related Protein; Interleukin 1 Family, Member 7
- 編號(hào)APE842Hu02
- 物種Homo sapiens (Human,人) 相同的名稱(chēng),不同的物種。
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)8.9
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1327 ¥ 3318 ¥ 6636 ¥ 19908 ¥ 49770
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
活性實(shí)驗(yàn)
Interleukin 37, also known as Interleukin 1 Zeta (IL1z), is an anti-inflammatory cytokine. Interleukines are cytokines that make an important part of immune signaling. It belongs to the interleukin-1 family. IL-37 plays a role in protecting the body against endotoxin shock, ischemia-reperfusion injury, autoimmune diseases, and cardiovascular diseases. In addition, IL-37 has a potential antitumor effect. Besides, Interleukin 18 Receptor 1 (IL18R1) has been identified as an interactor of IL1z, thus a binding ELISA assay was conducted to detect the interaction of recombinant human IL1z and recombinant human IL18R1. Briefly, IL1z were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100μl were then transferred to IL18R1-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-IL1z pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μl stop solution to the wells and read at 450nm immediately. The binding activity of IL1z and IL18R1 was shown in Figure 1, and this effect was in a dose dependent manner.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APE842Hu01 | 白介素1ζ(IL1z)活性蛋白 | Cell?culture;?Activity?Assays. |
RPE842Hu01 | 白介素1ζ(IL1z)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPE842Hu02 | 白介素1ζ(IL1z)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APE842Hu02 | 白介素1ζ(IL1z)活性蛋白 | Cell?culture;?Activity?Assays. |
PAE842Hu01 | 白介素1ζ(IL1z)多克隆抗體 | WB; IHC; ICC; IP. |
PAE842Hu02 | 白介素1ζ(IL1z)多克隆抗體 | WB; IHC; ICC; IP. |
LAE842Hu81 | 白介素1ζ(IL1z)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
LAE842Hu71 | 白介素1ζ(IL1z)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAE842Hu22 | 白介素1ζ(IL1z)單克隆抗體 | WB; IHC; ICC; IP. |
SEE842Hu | 白介素1ζ(IL1z)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCE842Hu | 白介素1ζ(IL1z)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LME842Hu | 白介素1ζ(IL1z)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Journal of Periodontal Research | Levels of interleukin-37 in gingival crevicular fluid, saliva, or plasma in periodontal disease [Pubmed:25399716] |
Arthritis research & therapy | Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout. [pubmed:27863506] |
Thoracic?Cancer? | IL‐37 inhibits invasion and metastasis in non‐small cell lung cancer by suppressing the IL‐6/STAT3 signaling pathway [Pubmed:29575809] |